Allogene Therapeutics, Inc. (ALLO)
2.31
-0.22
(-8.70%)
USD |
NASDAQ |
Mar 05, 16:00
2.31
0.00 (0.00%)
After-Hours: 20:00
Allogene Therapeutics Cash from Investing (TTM) : 116.88M for Sept. 30, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| ANI Pharmaceuticals, Inc. | -34.32M |
| Agenus, Inc. | 0.393M |
| Curis, Inc. | -0.428M |
| LadRx Corp. | 0.00 |
| Plus Therapeutics, Inc. | 0.287M |